A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation
Clinical trial NCT01682863 · COMPLETED
Trial details
- NCT number
- NCT01682863
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-06-01
- Enrollment
- 614
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.